Leaflet CASODEX 50mg film-coated tablets

Product code:
W65076001
Quantity:
28
Indicated for:
prostate cancer
Route of administration:
oral
Substance:
bicalutamide (antiandrogen)
ATC
L02BB03 — Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-androgens
Bicalutamide is an antiandrogen medication primarily used for the treatment of advanced prostate cancer. It works by blocking androgen receptors, thereby reducing the effects of male hormones (testosterone) on prostate cancer cells. It is often used in combination with other therapies, such as gonadotropin-releasing hormone (GnRH) analogs.

Bicalutamide is taken orally, usually once daily, and is well-tolerated by most patients. Common side effects include hot flashes, breast tenderness or enlargement (gynecomastia), fatigue, and nausea. In rare cases, it may affect liver function, so regular liver monitoring is recommended.

The medication is contraindicated in women, especially during pregnancy or breastfeeding, and is not recommended for use in children. It is important for patients to strictly follow their doctor’s instructions and not discontinue treatment without medical advice.

General data about CASODEX 50mg

Substance:
bicalutamide
Date of latest medicines list:
01-06-2026
Product code:
W65076001
Concentration:
50mg
Pharmaceutical form:
film-coated tablets
Quantity:
28
Product type:
Original
Price:
185.54 RON
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
CORDEN PHARMA GMBH - GERMANIA
Holder:
ASTRAZENECA AB - SUEDIA
Number:
8524/2016/01
Shelf life:
5 years

Concentrations available for bicalutamide

  • 150mg
  • 50mg

Compensation lists for CASODEX 50mg AstraZeneca

NHP 3 (C2) - NHP oncology

Price
185.54 RON
Copayment
73.79 RON
Patient
111.75 RON